Regulation of Protease-activated Receptor-1 Signaling
Regulation of Protease-activated Receptor-1 Signaling
批准号:
7339647
负责人:
Joann Trejo
金额:
$3.28万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-01 至 2008-03-31
关键词:
Adaptor Signaling ProteinArrestinArrestinsBindingBlood PlateletsBlood VesselsCOS-7 CellCardiovascular DiseasesCellsClathrinCoagulantsCouplesCouplingCytoplasmic TailDevelopmentDiffuseDown-RegulationDynaminEmbryoEndopeptidasesEndothelial CellsEventFamilyFibroblastsG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenerationsGoalsHemostatic functionHumanInflammatoryKnock-outLigand BindingLigandsLysosomesMediatingMediator of activation proteinMolecularMusPAR-1 ReceptorPathway interactionsPeptide HydrolasesPhosphorylationPrevention strategyProcessPropertyProteinase-Activated ReceptorsReceptor SignalingRegulationRelative (related person)RoleSignal TransductionSmooth Muscle MyocytesSorting - Cell MovementThrombinThrombosisTyrosineVascular SystemWound Healingatherogenesisbasecell typecoated pitdesensitizationnovelprototypereceptorresponsesorting nexinstrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this proposal is to understand the mechanisms of thrombin-regulated signaling. Thrombin, a coagulant protease, elicits a variety of cellular effects that are essential for hemostasis and thrombosis, as well as inflammatory and proliferative responses produced by vascular damage. Therefore, understanding the mechanisms of thrombin signaling may provide new strategies for the prevention and treatment of thrombin-related cardiovascular diseases. Protease-activated receptors (PARs) are G protein-coupled receptors (GPCRs) that mediate most of thrombin responses in cells. PAR1, the prototype of this family, is the predominant mediator of thrombin signaling in human platelets, as well as in endothelial cells, fibroblasts and smooth muscle cells. PAR1 is irreversibly proteolytically activated, intemalized and sorted directly to lysosomes. The mechanisms that contribute to termination of PAR1 signaling are not clearly understood. Betaarrestins bind to most phosphorylated GPCRs to mediate desensitization and internalization. Phosphorylation is important for termination of PAR1 signaling (at least to Gq). We found that Betaarr1 is the predominant mediator of PAR1 uncoupling to Gq signaling. PAR1 couples to Gq, Gi, and G12/13, and the molecular basis of PAR1 uncoupling to these distinct G protein subtypes is not known. We will use mouse embryonic fibroblasts (MEFs) derived from betaarrestin knockouts and COS-7 cells to delineate the role of ?arrestins in PAR1 signaling. Internalization and lysosomal sorting of activated PAR1 are also critical for termination of receptor signaling. PAR1 is internalized via a clathrin- and dynamin-dependent pathway that is independent of arrestins. We provide initial evidence that a tyrosine-based motif and perhaps a novel adaptor protein regulate internalization of PAR1. Finally, our studies demonstrate a novel role for SNX1 and perhaps SNX2 in regulating lysosomal sorting of PAR1 and raise the exciting possibility that SNXs function generally in GPCR trafficking. The specific aims of this proposal are to: (1) delineate the molecular basis of PAR1 desensitization, (2) define the novel internalization properties of PAR1, and (3) define the molecular mechanisms by which sorting nexins regulate lysosomal degradation of activated PAR1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endothelial Cytoprotective Signaling by Activated Protein C/Protease-activated Receptor-1
-
批准号:10816153
-
项目类别:
-
资助金额:$4.98万
-
财政年份:2023
-
负责人:Joann Trejo
-
依托单位:
Endothelial Cytoprotective Signaling by Activated Protein C/Protease-activated Receptor-1
-
批准号:10594367
-
项目类别:
-
资助金额:$60.47万
-
财政年份:2023
-
负责人:Joann Trejo
-
依托单位:
UC San Diego FIRST Program
-
批准号:10494788
-
项目类别:
-
资助金额:$15.8万
-
财政年份:2022
-
负责人:Joann Trejo
-
依托单位:
UC San Diego FIRST Program
-
批准号:10701795
-
项目类别:
-
资助金额:$473.21万
-
财政年份:2022
-
负责人:Joann Trejo
-
依托单位:
Cell Signaling by Protease-activated G Protein-coupled Receptors
-
批准号:10371096
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2018
-
负责人:Joann Trejo
-
依托单位:
Cell signaling by G protein-coupled receptors
-
批准号:10623554
-
项目类别:
-
资助金额:$53.09万
-
财政年份:2018
-
负责人:Joann Trejo
-
依托单位:
Cell Signaling by Protease-activated G Protein-coupled Receptors
-
批准号:9919120
-
项目类别:
-
资助金额:$2.92万
-
财政年份:2018
-
负责人:Joann Trejo
-
依托单位:
Cell Signaling by Protease-activated G Protein-coupled Receptors
-
批准号:9486492
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2018
-
负责人:Joann Trejo
-
依托单位:
Cell Signaling by Protease-activated G Protein-coupled Receptors
-
批准号:9891860
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2018
-
负责人:Joann Trejo
-
依托单位:
2013 Molecular Pharmacology Gordon Research Conference and Gordon Research Semina
-
批准号:8520657
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8209041
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8652182
-
项目类别:
-
资助金额:$32.94万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8400892
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8907624
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8792621
-
项目类别:
-
资助金额:$32.94万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8006389
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:7807578
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Mechanisms Regulating GPCR Trafficking
-
批准号:8073721
-
项目类别:
-
资助金额:$9.58万
-
财政年份:2010
-
负责人:Joann Trejo
-
依托单位:
Regulation of Protease-activated Receptor-1 Signaling
-
批准号:6839936
-
项目类别:
-
资助金额:$40.52万
-
财政年份:2004
-
负责人:Joann Trejo
-
依托单位:
Regulation of Protease-activated Receptor-1 Signaling
-
批准号:8207979
-
项目类别:
-
资助金额:$44.74万
-
财政年份:2004
-
负责人:Joann Trejo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
坡模酸通过抑制β-arrestin2介导的M2型巨噬细胞极化抗肝纤维化的机制研究
-
批准号:2026JJ81069
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱萱
-
依托单位:
电针刺激ST36通过DRD1/β-arrestin1信
号通路抑制炎症性骨丢失的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:刘冠峤
-
依托单位:
电针激活β-arrestin 1/IFN通路促进“冷-热”免疫表型转化协同IDO抑制剂治疗MSS肠癌的机制研究
-
批准号:
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:时佳琪
-
依托单位:
电针激活β-arrestin 1/IFN通路促进"冷-热"免疫表型转化协同IDO抑制剂治疗MSS肠癌的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:时佳琪
-
依托单位:
催产素系统通过β-arrestin2下调IL-25表达改善IBS-D肠道低度炎症的机制研究
-
批准号:82300613
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:于祎昂
-
依托单位:
GRK3激活β-arrestin-网格蛋白促进EGFR内吞导致结直肠癌西妥昔单抗治疗耐药的机制研究
-
批准号:82303846
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李源
-
依托单位:
CB2R-β-arrestin1抑制小胶质细胞代谢重编程调控神经炎症在改善POCD中的机制研究
-
批准号:82360227
-
项目类别:地区科学基金项目
-
资助金额:32.2万元
-
批准年份:2023
-
负责人:张列亮
-
依托单位:
L-dopa通过外泌体miRNA-301b靶向调控β-arrestin2下调激活D1R信号通路参与帕金森病异动症的机制研究
-
批准号:LZ23H090001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:谢成龙
-
依托单位:
GPR120通过β-Arrestin2介导糖尿病性ED阴茎海绵体内皮损伤修复机制的研究
-
批准号:82371633
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:林浩成
-
依托单位:
基于GPR43/β-arrestin2通路探讨八正散调节肠道菌群介导短链脂肪酸代谢抑制肾结石氧化应激反应的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位: